MedTrace Logo

Immune Damage and Vaccination in COPD Patients

NCT03804138 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2023-04-14

No results posted yet for this study

Summary

Better understanding of the specificities of the vaccine response in patients with COPD

Conditions

Interventions

OTHER

Anti-influenza and DTp pertussis vaccinations

Anti-influenza and DTp pertussis vaccinations will be performed during the visit by the clinical research nurse. The vaccine has been prescribed as part of the care either by the patient's physician (pulmonologist or general practitioner).

Sponsors & Collaborators

  • Centre Hospitalier Intercommunal Creteil

    lead OTHER

Principal Investigators

  • Laurent Boyer, MD · CHU Henri-Mondor

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-09
Primary Completion
2021-02-03
Completion
2023-02-03

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03804138 on ClinicalTrials.gov